Genio Technologies, Inc. is a team of bold inventors, doctors, scientists, and business experts focused on shifting the paradigms of diagnostic innovation.
Joined August 2020
- Tweets46
- Following39
- Followers34
- Likes57
Pinned Tweet
The use of #massspectrometry in the #clinic, including intraoperative use of the precìso system , was selected at one of seven technologies to watch in 2021 by @nature! Learn more about precìso and other amazing tools that are making an impact this year nature.com/articles/d41586-0…
We're so grateful to be recognized by @thetechtrib as one of the best tech start-ups in Tulsa of 2022! Always great to be among good company in Oklahoma! thetechtribune.com/2-best-te…
Genio Technologies retweeted
Collaborative work from the Eberlin lab @livia__se describes a new design of the MasSpec Pen technology integrated to electrospray ionization (ESI) for direct analysis of nasopharyngeal swabs for COVID-19 screening. pubs.acs.org/doi/10.1021/acs…
Genio Technologies retweeted
A huge effort and international collaboration 🍾! This was such an exciting project to work on
Collaborative work from the Eberlin lab @livia__se describes a new design of the MasSpec Pen technology integrated to electrospray ionization (ESI) for direct analysis of nasopharyngeal swabs for COVID-19 screening. pubs.acs.org/doi/10.1021/acs…
COVID-19 has challenged us all to use our technologies in new ways to help us tackle the #pandemic. See how the precìso MasSpec Pen can be implemented for rapid #covid19 testing in our newest publication, out now in @an_chem pubs.acs.org/doi/10.1021/acs…
Genio Technologies retweeted
Great day for #surgicalinnovation @MDAndersonNews #oncsurgery and @EberlinLab with start of our #MasSpecPen protocol in #ovariancancer surgery! #endcancer @AnilSoodMD @ShannonWestin @RossFH @HanTCun @karenluMD @drjustinbird @sgswisher
Genio Technologies retweeted
Now published as a peer-reviewed article at @Clin_Chem_AACC, our feasibility study showing translation of the MasSpec Pen to the operating room. Incredible amount of work went into this study, proud of the team that made it possible! academic.oup.com/clinchem/ad…
Hot off the presses! Check out how the preciso MasSpec Pen is being used intraoperatively and see how mass spectrometry is coming to an OR sooner than you may think. Peer reviewed article out now! academic.oup.com/clinchem/ad…
Genio Technologies retweeted
Groundbreaking news involving Genio Technologies & its MasSpec Pen diagnostic tool. The scientific publication, Futurity, reported MasSpec Pen system has been tested for the first time with positive results in pancreatic cancer patients during surgery. bit.ly/3r9mfpj
Genio Technologies retweeted
Groundbreaking news involving Genio Technologies & its MasSpec Pen diagnostic tool. The scientific publication, Futurity, reported MasSpec Pen system has been tested for the first time with positive results in pancreatic cancer patients during surgery. bit.ly/3r9mfpj
Genio Technologies retweeted
A diagnostic tool called the MasSpec Pen has been tested for the first time in pancreatic cancer patients during surgery to identify margins between healthy and cancerous tissue, which can help give pancreatic cancer patients a greater chance of survival. buff.ly/3AEzeUl
Genio Technologies retweeted
From our incredible collaborator, surgeon @GeorgeVanBuren, “The MasSpec Pen technology opens the door for real time, precision medicine to be performed in the operating room at a level that has never been seen before.” news.utexas.edu/2021/07/05/m…
Genio Technologies retweeted
Excited to collaborate with our colleagues at UT Austin on improving pancreas cancer care @EberlinLab @jsuliburk @BCM_Surgery @BCM_CancerEd @BCMCancerCenter @CHI_Updates @qualitybslmc – at West University Place, TX
From our incredible collaborator, surgeon @GeorgeVanBuren, “The MasSpec Pen technology opens the door for real time, precision medicine to be performed in the operating room at a level that has never been seen before.” news.utexas.edu/2021/07/05/m…
Genio Technologies retweeted
Proud to be a Texas Longhorn and collaborate with @UTAustin on the treatment of pancreas cancer. Hook Em @EberlinLab @UTAustin @BCM_Surgery @BCMCancerCenter @jsuliburk @williamefisher @PanCAN @PancanHouston @NatPancFdn – at West University Place, TX
The MasSpec Pen was tested for the first time in pancreatic cancer patients during surgery and it accurately identified tissues and surgical margins. The team from @UTAustin and @BCMFromtheLabs report results in @PNASNews. cns.utexas.edu/news/masspec-… @livia__se, @UTChemistry
Genio Technologies retweeted
We are so excited to share our first diagnostic results from testing the MasSpec Pen in pancreatic cancer surgery at @bcmhouston in our latest article, out now in @PNASNews ! @jsuliburk @GeorgeVanBuren @williamefisher pnas.org/content/118/28/e210…
Genio Technologies retweeted
The CPRIT-supported MasSpec Pen from @livia__se at @TexasScience is showing promise in pancreatic cancer surgery. Dr. Eberlin has received $2.3 million in CPRIT grants that have contributed to the development of this innovative device. Read more here: cprit.us/3wlUjQ3
Achieving clear surgical margins is key to the successful treatment of pancreatic cancer. The preciso MasSpec Pen can aid surgeons in performing this difficult task during highly complex procedures. See how in this recent article! pnas.org/content/118/28/e210…
Genio Technologies retweeted
Our portfolio company, Genio Technologies, celebrates another use of its MasSpec Pen System as a potential tool for fast COVID-19 screens. Read the article about the study in the health science publication, medRxiv.
@GenioTech_io
medrxiv.org/content/10.1101/…
Small molecules can be diagnostic of more than just cancer. During the pandemic, we explored using our MasSpec Pen technology as a rapid diagnostic tool for COVID-19 as an alternative to traditional methods. Check out the preprint on this work now! medrxiv.org/content/10.1101/…
Genio Technologies retweeted
A Mass Spec in every OR is a pretty awesome future to look forward to!
WE ARE BACK IN THE OR! After an unfortunate pause due to covid19 restrictions, our team is back in the OR testing the MasSpec Pen in cancer surgeries! Amazing effort from our research and clinical team! Go mass spec! #masspecpen #cancersurgery @jsuliburk @BCM_Surgery
We're happy to see the MasSpec Pen back in action!
WE ARE BACK IN THE OR! After an unfortunate pause due to covid19 restrictions, our team is back in the OR testing the MasSpec Pen in cancer surgeries! Amazing effort from our research and clinical team! Go mass spec! #masspecpen #cancersurgery @jsuliburk @BCM_Surgery